People with severe sepsis could one day be treated by having their blood filtered to remove a crucial protein that seems to drive the life-threatening reaction. The approach has shown promise in animal models, with aims for a trial in people next year.
Sepsis occurs when the body’s immune system overreacts to an infection, damaging tissues and organs. It can also escalate into septic shock, in whi...
This report presents a compelling but preliminary case for targeting galectin-3 in sepsis treatment. The strongest version of the narrative highlights a clear unmet need—sepsis remains a major killer despite existing therapies—and offers a mechanistically plausible intervention with promising animal data. The use of apheresis, a clinically established technique, lends credibility to the approach.
However, several patterns warrant scrutiny. The framing leans toward **ARC-0012 Hope Marketing**, em...